Related references
Note: Only part of the references are listed.Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients
David M. Smadja et al.
ANGIOGENESIS (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Circulating angiopoietin-2 and the risk of mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis of 10 prospective cohort studies
Fengyuan Li et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2020)
Circulating markers of angiogenesis and endotheliopathy in COVID-19
Matthew L. Meizlish et al.
PULMONARY CIRCULATION (2020)
BLOCKADE OF ENDOTHELIAL GROWTH FACTOR, ANGIOPOIETIN-2, REDUCES INDICES OF ARDS AND MORTALITY IN MICE RESULTING FROM THE DUAL-INSULTS OF HEMORRHAGIC SHOCK AND SEPSIS
Joanne L. Lomas-Neira et al.
SHOCK (2016)
Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance
Carolyn S. Calfee et al.
CRITICAL CARE MEDICINE (2012)
The angiopoietin-Tie2 system as a therapeutic target in sepsis and acute lung injury
Melanie van der Heijden et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Intra and extravascular transmembrane signalling of angiopoietin-1-Tie2 receptor in health and disease
T. Makinde et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Inhibition of In vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer
Shiva Sarraf-Yazdi et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Angiopoietins: a link between angiogenesis and inflammation
Ulrike Fiedler et al.
TRENDS IN IMMUNOLOGY (2006)
Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans
SM Parikh et al.
PLOS MEDICINE (2006)
Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation
U Fiedler et al.
NATURE MEDICINE (2006)
The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism
M Scharpfenecker et al.
JOURNAL OF CELL SCIENCE (2005)
Pulmonary pathology of severe acute respiratory syndrome in Toronto
DM Hwang et al.
MODERN PATHOLOGY (2005)
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
J Oliner et al.
CANCER CELL (2004)
Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2
RR White et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway
I Kim et al.
ONCOGENE (2000)
Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway
A Papapetropoulos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway
I Kim et al.
CIRCULATION RESEARCH (2000)